INTRODUCTION
The generation of reactive oxygen species (ROS) in blood is a very important biomarker for both innate immunology [1] [2] [3] and cellular fibrinolysis [4] . The active oxidative burst enzyme NADPH-oxidase consists of the subunits gp91PHOX/p22 PHOX in the plasma membrane, of the subunits p67 PHOX/p47 PHOX in the cytosol, and of the regulator Rac2; the cofactor of the enzyme is NADPH, generated by glucose metabolism [5, 6] . Therefore, changes of the conc. of blood glucose, the precursor of glucose-6-phosphate, could well influence blood ROS generation. The aim of the present work was to find out if blood glucose concentrations that would be typical for diabetes mellitus modulate blood ROS generation.
MATERIAL AND METHODS
Citrated blood (4.5 ml venous blood drawn into polypropylene monovettes containing 0.5 ml 106 mM sodium citrate; Sarstedt, Nümbrecht, Germany) or EDTA blood (2.6 ml venous blood drawn into polypropylene monovettes containing 1.6 mg/ml K3-ethylene diamine tetra acetate (EDTA); Sarstedt) of 6 healthy donors that gave written consent after explanation were analyzed in the blood ROS generation assay (BRGA) [7, 8] : 10 µl sample in black high quality polystyrene F-microwells (Brand, Wertheim, Germany; article nr. 781608) were incubated in triplicate with 125 µl Hanks' balanced salt solution (HBSS; modified without phenol red; SAFC Biosciences-Sigma, Deisenhofen, Germany; article nr. 55037C-1000ML), 40 µl 0 -200 mM glucose in 0.9% NaCl (final added concentration: 0 -41 mM; final basal glucose concentration: about 4 mM), 10 µl 5 mM luminol sodium salt (Sigma; article nr. A4685-1G; 1 g dissolved in 25.1 ml resulted in a 200 mM stem solution) in 0.9% NaCl, and 10 µl 36 µg/ml zymosan A (ZyA; Sigma, Deisenhofen, Germany; article nr. Z-4250-1G, lot nr. 27H0495), final conc.: 1.9 µg/ml. The plates were measured within 0 -250 min (37˚C) in a photons-multiplyer microtiter plate luminometer (LUmo; anthos, Krefeld, Germany) with an integration time of 1 s. The approximate 200% stimulatory (approx. SC200) or 50% inhibitory (approx. IC50) conc. of added glucose on oxidative blood burst were determined.
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RESULTS
Citrated blood in the BRGA had a ROS maximum of about 1600 relative light units per second (RLU/s) obtained after about 60 min (37˚C). Half-maximal blood ROS generation was reached at about 35 min or at about 120 min (Figure 1) .
EDTA-blood in the BRGA had also a ROS maximum of about 1600 RLU/s after about 80 min (37˚C), i.e. 20 min later than citrated blood. Half-maximal blood ROS generation was reached at about 50 min or at about 130 min (Figure 2) . At 80 min, 94 min, or 104 min the mean ROS generation nearly doubled at about 1 mM or at about 21 mM added glucose (Figures 7-9) .
At 162 min or 182 min the approx. SC200 of mean ROS generation was 1 mM or 11 mM added glucose (Figures 10 and 11) . A similar approx. SC200 of mean ROS generation, however at much lower RLU/s, was found for 250 min (Figure 12) .
Figures 13-16 describe individual and mean ROS generations in EDTA blood:
At 27 min reaction time 1 mM added glucose inhibited about 50% of mean ROS generation (approx. IC50 = 1 mM added glucose) (Figure 13) .
At 80 min or 113 min there appeared neither an IC50 nor a SC200 for mean ROS generation (Figures 14 and  15) .
At 182 min the approx. SC200 for mean ROS generation was 21 mM added glucose (Figure 16) .
Thus, citrated blood is better than EDTA-blood to estimate changes of oxidative burst. ROS generation in EDTA-blood responded rather blunted to glucose altera- tions, the refined changes of ROS generation in citrated blood are demonstrated in Table 1 , the reaction times of 38 min and 46 min being in the change phase from inhibition to stimulation. 1 mM glucose is only 20% of the normal plasma concentration of glucose that is about 5 mM. Similar to the intrinsic activation of hemostasis by glucose, added glucose maximally enhanced blood ROS generation at more than one concentration [9] [10] [11] , the first (and most important one) being at about 1 mM and the second one being at 21 mM or 11 mM, depending on the reaction time. 
DISCUSSION
There has already been evidence that glucose can alter blood ROS generation [12] [13] [14] [15] [16] [17] [18] [19] : 11 mM glucose reduced the neutrophils' respiratory burst by 28% ± 5% and 56 mM glucose by 74% ± 7% [12] . 50% decreased ROS generation was detected at 25 mM glucose [13] . Lowering of blood glucose levels by insulin treatment of diabetic patients improved neutrophil functional activity [20] . The present work was undertaken in the new BRGA because the previous findings were not measured in whole blood that is the physiologic matrix of activated neutrophils. The main cell in blood that is competent for massive oxidative burst explosion is the neutrophil [21] [22] [23] [24] ] that generates about 60 fmoles H 2 O 2 per 30 min (21˚C), whereas the monocyte generates less than 10% of this amount [21] .
An ideal ROS detection technique should [25] :  Imitate the physiologic ROS generation response to blood pathogens;  Imitate the pathophysiologic blood ROS generation in autoimmunity;  Detect globally the most important ROS of blood, that are hydrogen peroxide and singlet oxygen;  Use a stable pathophysiologic trigger such as hydrophilic zymosan A (ZyA) [26, 27] ;  Be sensitive enough to detect ROS upon blood stimulation by only 1 -2 µg/ml ZyA (the approx. concentration of initial severe fungal sepsis [28] );  Not interfere with cell function (using untoxic concentrations of the light enhancer luminol);  Be cheap: without taxes one LUmo (microtiter plate luminometer) costs less than €4500;  Use a close-to-physiologic buffered salt solution [29] ;  Be easy to standardize;  Dilute whole blood only 10 -20 fold, higher dilutions result in unphysiologic matrix [30] ;  Be suitable for routine measurements of hundreds of samples within minutes.
The new BRGA technique with 18 -20 fold diluted whole blood fulfils all these requirements. This refined blood ROS test demonstrated that at incubation times less than 30 min a blood glucose increase of only about 1 mM resulted in 50% less ROS generation. Incubation times higher than 80 min resulted in 100% increased ROS generation by about 1 mM added glucose. This time is possibly necessary for full phosphorylation in the correct cell compartment of glucose to glucose-6-phosphate (G6P), the substrate metabolized by G6P-dehydrogenase to generate NADPH, the cofactor of the NADPH-oxidase. This means that in the acute phase of blood neutrophil activation, such as the physicologic response to micro-or macro-thrombi, the diabetic patient has a decreased cellular fibrinolysis [6, 31] .
By contrast, in the chronic phase of neutrophil activation, the diabetic patient suffers of increased systemic inflammation [32, 33] . Of particular interest is the diabetic patient in pregnancy, where increased ROS generation can threaten the health of mother and unborn [34] . Interestingly, the healthy placenta produces large quantities of the macrophage derived plasminogen activator inhibitor (PAI)-2, a suppressor of fetal rejection and autoimmunity [35, 36] . A physiologic drug "PAI-2" could replace glucocorticoids with dangerous side reactions [37] .
In conclusion, the elevated glucose concentration in diabetes mellitus not only increases systemic thrombin generation [9] [10] [11] [38] [39] [40] , it might also diminish cellular fibrinolysis and increase systemic inflammation [41, 42] , resulting in a chronic pro-thrombotic state [43] .
Furthermore, the fascinating importance of NADPHoxidases not only in phagocytes but also in the beta cells of pancreas [44] points towards a totally new pathogenesis explication of diabetes mellitus type 1 [45] [46] [47] : whatever stimulus (e.g. a pancreas-tropic virus) such as mumps virus, coxsackie B, cytomegalovirus (CMV), EpsteinBarr virus (EBV) could activate the beta cell's NADPHoxidase. The generated ROS could auto-destroy the insulin producing cells [48, 49] . Is PAI-2 a new drug against the development of type 1-diabetes mellitus [50] ?
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